Updates are available Correction dated 2022-10-20
Click to view Correction: https://doi.org/10.1007/s40261-022-01212-z
Updates are available Correction dated 2023-01-27
Click to view Correction: https://doi.org/10.1007/s40261-022-01239-2
-
Authors
Figueiredo, Arnaldo
Costa, Luís
Maurício, Maria Joaquina
Figueira, Luís
Ramos, Rodrigo
Martins-da-Silva, Carlos
-
Funding
Funding for this research was provided by:
Bayer
- License Information
-
More Information
Article History
Accepted: 21 June 2022
First Online: 13 July 2022
Change Date: 20 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40261-022-01212-z
Change Date: 27 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40261-022-01239-2
Declarations
:
: Bayer financially supported the medical writing company Prime Focus by providing writing assistance.
: AF received honoraria as a consultant/speaker for Astellas, AstraZeneca, Bayer, BMS, Janssen, MSD, Novartis, Pfizer, Recordati, and Roche. LC received honoraria as a consultant/speaker for Astellas, Bayer, BMS, Janssen, MSD, Roche, and Servier. MJM received honoraria as a consultant/speaker for Bayer, BMS, Janssen, MSD, Ipsen, and Pfizer. RR received honoraria as a consultant/speaker for Bayer, Janssen, and Pfizer. LF and CMS have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the review of the literature, article elaboration, and revision. All authors gave their final approval of the submitted version.
